Acquisitions, de novos, integration, EBITDA, and enterprise value creation.
Physician group private equity deal volume fell from 28% of global provider transactions in 2021 to 23% in 2025, per Bain & Company’s 2026 Global Healthcare Private Equity…
Sixty-nine percent of DSOs expect their private equity sponsors to push for moderate-to-high increases in acquisition activity in 2026, according to TUSK Practice Sales’ Q2 2026 Dental Market…
Ambulatory surgery center M&A deal flow is holding steady in 2026, with both private equity and health systems actively deploying capital at scale. USPI committed $125 million in…
De novo healthcare locations routinely underperform in their first months because media plans launch too late—often just weeks before opening, when the algorithm still needs time to learn….
.hg-beta{background:#0B1120;color:#64748B;text-align:center;font-size:10px;letter-spacing:.12em;text-transform:uppercase;padding:7px 20px;font-family:inherit;border-bottom:1px solid rgba(255,255,255,.04)} .hg-beta strong{color:#10B981;margin-right:6px} .hg-header{position:fixed;top:0;left:0;right:0;z-index:9999} body.admin-bar .hg-header{top:32px} @media screen and (max-width:782px){body.admin-bar .hg-header{top:46px}} .hg-header-space{height:82px} .hg-nav-root{background:#0B1525;border Behavioral Health Business · June 3, 2026 · 6 min read READ…
Dental M&A in 2026 has moved from “growth at any cost” to operational discipline, according to new data from TUSK Practice Sales. Although 69% of DSOs plan to…
Ambulatory surgery center M&A remains active in 2026, with private equity and health systems both accelerating acquisition pace. Tenet Healthcare’s USPI deployed $125 million in Q1 2026 alone…
The FTC approved Ascension’s $3.9 billion acquisition of AmSurg, the nation’s largest independent ambulatory surgery center operator, under a consent order issued June 2, 2026. To preserve competition,…
Patients have built a parallel healthcare infrastructure—virtual clinics, diagnostic tools, direct-pay platforms, and consumer health apps—driven by fragmented care experiences, opaque pricing, and limited specialist access. This “shadow…
Four structural headwinds are challenging DSO acquisition plans in 2026: low practice supply, elevated interest rates, mounting state legislative oversight, and projected federal Medicaid cuts of $664 billion…
